<DOC>
	<DOC>NCT01569737</DOC>
	<brief_summary>The study is aimed at assessing the clinical follow-up and the outcomes of pregnancies exposed to ella, whether due to failure of the emergency contraception or inadvertent exposure during pregnancy.</brief_summary>
	<brief_title>Clinical Follow-up and Outcomes of Pregnancies Exposed to Ella</brief_title>
	<detailed_description />
	<mesh_term>Emergencies</mesh_term>
	<criteria>Pregnant women, exposed to ella during the menstrual cycle in which the pregnancy started (treatment failure) or at any time during pregnancy (inadvertent exposure during pregnancy) Adolescents and/or adults in the USA, depending on the respective State law</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>ella</keyword>
	<keyword>ulipristal acetate</keyword>
	<keyword>pregnancy</keyword>
	<keyword>emergency contraception</keyword>
</DOC>